Abstract
AimAnakinra, an anti IL-1 agent targeting IL-1 alfa and beta, is available for the treatment of recurrent pericarditis in cases with corticosteroid dependence and colchicine resistance after failure of conventional...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have